Company
Centinel Spine
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
10
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
147
Received Nov 1, 2025 to Nov 20, 2026
Recall records
6
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$48.9M
4 Form D offerings, 2017 to 2024
Equity
$40.5M
Stock sold for cash
Debt and convertible notes
$8.4M
$8.4M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: convertible note, $3.2M raised of $10.0M sought, first sale Mar 11, 2024, 5 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2024 | Convertible note | $3.2M | $10.0M | 5 | Rule 506(b) | Form D ↗Mar 18, 2024 |
3 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Centinel Spine, LLC
- Headquarters
- West Chester, Pennsylvania
- Incorporated
- Delaware over five years before filing
- Entity type
- Limited Liability Company
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1727729 ↗
Executives, directors and promoters
As listed on the latest Form D.
10 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Centinel Spine.
Latest FDA decisions
The 8 newest of 10 since 2015.
K263159 · Decided Oct 7, 2026 · 28 days after receipt
Device type: Manual Instruments Designed For Use With Total Disc Replacement Devices (QLQ) · Orthopedic Surgery
9 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo DevicesEnrolling by invitation
NCT07370493 · 200 participants (planned) · Start Nov 1, 2025 · Primary completion Dec 2030
Device: Prodisc C Vivo · For: Degenerative Disc Disease; Cervical Spine Degenerative Disease; Symptomatic Cervical Disc Disease and 1 more
Sites: Recklinghausen, Germany
2 more trials with a free account
Reports received
147
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
20
14% of reports
Injury reports
127
86% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 9 | 0 | 0 |
| Jan 24 | 0 | 8 | 0 | 0 |
| Feb 24 | 0 | 8 | 0 | 0 |
| Mar 24 | 0 | 11 | 0 | 0 |
| Apr 24 | 0 | 4 | 0 | 0 |
| May 24 | 1 | 7 | 0 | 0 |
| Jun 24 | 1 | 2 | 0 | 0 |
| Jul 24 | 3 | 4 | 0 | 0 |
| Aug 24 | 0 | 14 | 0 | 0 |
| Sep 24 | 0 | 4 | 0 | 0 |
| Oct 24 | 3 | 5 | 0 | 0 |
| Nov 24 | 2 | 7 | 0 | 0 |
| Dec 24 | 2 | 10 | 0 | 0 |
| Jan 25 | 0 | 18 | 0 | 0 |
| Feb 25 | 3 | 5 | 0 | 0 |
| Mar 25 | 0 | 7 | 0 | 0 |
| Apr 25 | 0 | 7 | 0 | 0 |
| May 25 | 1 | 5 | 0 | 0 |
| Jun 25 | 3 | 6 | 0 | 0 |
| Jul 25 | 0 | 9 | 0 | 0 |
| Aug 25 | 6 | 3 | 0 | 0 |
| Sep 25 | 1 | 21 | 0 | 0 |
| Oct 25 | 0 | 12 | 0 | 0 |
| Nov 25 | 2 | 23 | 0 | 0 |
| Dec 25 | 0 | 13 | 0 | 0 |
| Jan 26 | 0 | 6 | 0 | 0 |
| Feb 26 | 1 | 3 | 0 | 0 |
| Mar 26 | 2 | 18 | 0 | 0 |
| Apr 26 | 2 | 11 | 0 | 0 |
| May 26 | 5 | 7 | 0 | 0 |
| Jun 26 | 0 | 8 | 0 | 0 |
| Jul 26 | 3 | 5 | 0 | 0 |
| Aug 26 | 0 | 14 | 0 | 0 |
| Sep 26 | 4 | 8 | 0 | 0 |
| Oct 26 | 1 | 11 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
The full in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Prodisc C SK U.S. IMPLANT EXTRA LARGE 5MM. Model: PDSXL5 Total cervical disc replacement.Open, Classified
Z-2050-2026 · Started Mar 20, 2026 · Posted by FDA May 1, 2026
Reason given: Product labeling mix up. The prodisc C SK U.S. Implant Extra Large 6mm product was labeled as a 5mm and prodisc C SK U.S. Implant Extra Large 5mm product was labeled as a 6mm.
Cause as FDA categorized it: Labeling mix-ups · Device type: Prosthesis, Intervertebral Disc (MJO)
5 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.